These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3516039)

  • 41. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia.
    Lauw FN; Branger J; Florquin S; Speelman P; van Deventer SJ; Akira S; van der Poll T
    J Immunol; 2002 Jan; 168(1):372-8. PubMed ID: 11751983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of aging on antibacterial mechanisms in experimental pneumonia.
    Esposito AL; Pennington JE
    Am Rev Respir Dis; 1983 Oct; 128(4):662-7. PubMed ID: 6354025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of IL-1 to resistance to Streptococcus pneumoniae infection.
    Kafka D; Ling E; Feldman G; Benharroch D; Voronov E; Givon-Lavi N; Iwakura Y; Dagan R; Apte RN; Mizrachi-Nebenzahl Y
    Int Immunol; 2008 Sep; 20(9):1139-46. PubMed ID: 18596024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Mouse Model of Post-Stroke Pneumonia Induced by Intra-Tracheal Inoculation with Streptococcus pneumoniae.
    Mracsko E; Stegemann-Koniszewski S; Na SY; Dalpke A; Bruder D; Lasitschka F; Veltkamp R
    Cerebrovasc Dis; 2017; 43(3-4):99-109. PubMed ID: 28049200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of severe pneumonia by hinokitiol in a murine antimicrobial-resistant pneumococcal pneumonia model.
    Isono T; Domon H; Nagai K; Maekawa T; Tamura H; Hiyoshi T; Yanagihara K; Kunitomo E; Takenaka S; Noiri Y; Terao Y
    PLoS One; 2020; 15(10):e0240329. PubMed ID: 33057343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia.
    Li L; Foo BJW; Kwok KW; Sakamoto N; Mukae H; Izumikawa K; Mandard S; Quenot JP; Lagrost L; Teh WK; Singh Kohli G; Zhu P; Choi H; Buist ML; Seet JE; Yang L; He F; Kwong Chow VT; Tan NS
    mBio; 2019 Jun; 10(3):. PubMed ID: 31164474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function.
    Yang Z; Chiou TT; Stossel TP; Kobzik L
    Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(1):L11-6. PubMed ID: 25957291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense.
    Knapp S; Wieland CW; van 't Veer C; Takeuchi O; Akira S; Florquin S; van der Poll T
    J Immunol; 2004 Mar; 172(5):3132-8. PubMed ID: 14978119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nrf2 Modulates Host Defense during Streptococcus pneumoniae Pneumonia in Mice.
    Gomez JC; Dang H; Martin JR; Doerschuk CM
    J Immunol; 2016 Oct; 197(7):2864-79. PubMed ID: 27566827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early pulmonary granulocyte recruitment in response to Streptococcus pneumoniae.
    Vial WC; Toews GB; Pierce AK
    Am Rev Respir Dis; 1984 Jan; 129(1):87-91. PubMed ID: 6703489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia.
    van der Poll T; Keogh CV; Guirao X; Buurman WA; Kopf M; Lowry SF
    J Infect Dis; 1997 Aug; 176(2):439-44. PubMed ID: 9237710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triggering receptor expressed on myeloid cells-1 (TREM-1) improves host defence in pneumococcal pneumonia.
    Hommes TJ; Hoogendijk AJ; Dessing MC; Van't Veer C; Florquin S; Colonna M; de Vos AF; van der Poll T
    J Pathol; 2014 Aug; 233(4):357-67. PubMed ID: 24752755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-inflammatory roles of mesenchymal stromal cells during acute Streptococcus pneumoniae pulmonary infection in mice.
    Asami T; Ishii M; Namkoong H; Yagi K; Tasaka S; Asakura T; Suzuki S; Kamo T; Okamori S; Kamata H; Zhang H; Hegab AE; Hasegawa N; Betsuyaku T
    Cytotherapy; 2018 Mar; 20(3):302-313. PubMed ID: 29397306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of β-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia.
    Yoshioka D; Kajiwara C; Ishii Y; Umeki K; Hiramatsu K; Kadota J; Tateda K
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6146-54. PubMed ID: 27480866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of galectin-3 in leukocyte recruitment in a murine model of lung infection by Streptococcus pneumoniae.
    Nieminen J; St-Pierre C; Bhaumik P; Poirier F; Sato S
    J Immunol; 2008 Feb; 180(4):2466-73. PubMed ID: 18250456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polyamine transporter in Streptococcus pneumoniae is essential for evading early innate immune responses in pneumococcal pneumonia.
    Rai AN; Thornton JA; Stokes J; Sunesara I; Swiatlo E; Nanduri B
    Sci Rep; 2016 Jun; 6():26964. PubMed ID: 27247105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia.
    Mohler J; Azoulay-Dupuis E; Amory-Rivier C; Mazoit JX; Bédos JP; Rieux V; Moine P
    Intensive Care Med; 2003 May; 29(5):808-16. PubMed ID: 12665994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia.
    Reppe K; Tschernig T; Lührmann A; van Laak V; Grote K; Zemlin MV; Gutbier B; Müller HC; Kursar M; Schütte H; Rosseau S; Pabst R; Suttorp N; Witzenrath M
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):474-81. PubMed ID: 18931326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Osteopontin impairs host defense during pneumococcal pneumonia.
    van der Windt GJ; Hoogendijk AJ; Schouten M; Hommes TJ; de Vos AF; Florquin S; van der Poll T
    J Infect Dis; 2011 Jun; 203(12):1850-8. PubMed ID: 21606543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of recombinant human granulocyte colony-stimulating factor in a murine model of pneumococcal pneumonia: effects of lung inflammation and timing of treatment.
    Dallaire F; Ouellet N; Simard M; Bergeron Y; Bergeron MG
    J Infect Dis; 2001 Jan; 183(1):70-7. PubMed ID: 11087202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.